Enliven Therapeutics, Inc. (ELVN)
45.38
-0.71
(-1.54%)
USD |
NASDAQ |
Sep 24, 09:55
Enliven Therapeutics Cash from Operations (TTM) : -66.94M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -66.94M |
| March 31, 2026 | -65.46M |
| December 31, 2025 | -70.30M |
| September 30, 2025 | -71.67M |
| June 30, 2025 | -70.58M |
| March 31, 2025 | -73.96M |
| December 31, 2024 | -73.19M |
| September 30, 2024 | -68.47M |
| June 30, 2024 | -72.17M |
| March 31, 2024 | -63.79M |
| December 31, 2023 | -61.27M |
| September 30, 2023 | -60.42M |
| Date | Value |
|---|---|
| June 30, 2023 | -50.98M |
| March 31, 2023 | -46.05M |
| December 31, 2022 | -35.57M |
| September 30, 2022 | -36.42M |
| June 30, 2022 | -40.87M |
| March 31, 2022 | -44.11M |
| December 31, 2021 | -46.77M |
| September 30, 2021 | -42.56M |
| June 30, 2021 | -42.00M |
| March 31, 2021 | -40.89M |
| December 31, 2020 | -37.40M |
| September 30, 2020 | -37.17M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Definium Therapeutics, Inc. | -166.74M |
| Cocrystal Pharma, Inc. | -8.263M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -207.00M |